Search Results

Test Catalog

LGBWB - Overview: Globotriaosylsphingosine, Blood

Screening of patients with Fabry disease when a serum specimen is not available This test should not be used for newborn screening followup.

MPA - Overview: Mycophenolic Acid, Serum

Monitoring therapy to ensure adequate blood levels and avoid over-immunosuppression

MOLPS - Overview: Molybdenum, Serum

Monitoring of parenteral nutrition Monitoring metallic prosthetic implant wear As an indicator of molybdenum cofactor deficiency

CSPCF - Overview: Plasma Cell Proliferative Disorder, Pre-Analysis Cell Sorting, Bone Marrow

Aiding in the diagnosis of new cases of multiple myeloma or other plasma cell proliferative disorders Sorting plasma cells for fluorescence in situ hybridization analysis

PRMB - Overview: Primidone and Phenobarbital, Serum

Assessing compliance Monitoring for appropriate therapeutic levels of primidone and phenobarbital Assessing toxicity

ROTA - Overview: Rotavirus Antigen, Feces

Investigation of patients with diarrhea, particularly infants, the elderly, and immunocompromised patients Investigation of nosocomial diarrhea

DSS - Overview: Drug Screen, Prescription/Over the Counter, Serum

Detection and identification of prescription or over the counter drugs frequently found in drug overdose or used with a suicidal intent Qualitatively identifying drugs present in the specimen; quantification of identified drugs, when...

PDSUX - Overview: Drug Screen, Prescription/Over the Counter, Chain of Custody, Random, Urine

Qualitative detection and identification of prescription or over-the-counter drugs frequently found in drug overdose or used with a suicidal intent Providing, when possible, the identification of all drugs in the specimen This test is...

CLOM - Overview: Clomipramine, Serum

Determining whether a poor therapeutic response is attributable to noncompliance Monitoring serum concentration of clomipramine and norclomipramine to assist in optimizing the administered dose

ALCX - Overview: Ethanol, Chain of Custody, Blood

Detection of ethanol (ethyl alcohol) in blood to document prior consumption or administration of ethanol Quantification of the concentration of ethanol in blood correlates directly with degree of intoxication All testing is performed...

FENR - Overview: Fentanyl Screen with Reflex, Random, Urine

Screening for drug abuse or use involving fentanyl and confirmation of fentanyl if present in the screen

KINET - Overview: Ki-67(MIB-1), Gastrointestinal/Pancreatic Neuroendocrine Tumors, Quantitative Immunohistochemistry, Automated

Determining proliferation of tumor cells in paraffin-embedded tissue blocks from patients diagnosed with neuroendocrine tumors of the pancreas or gastrointestinal tract including metastases

LAMO - Overview: Lamotrigine, Serum

Monitoring serum concentration of lamotrigine Assessing compliance Adjusting lamotrigine dose in patients receiving other anticonvulsant drugs that interact pharmacokinetically with lamotrigine

MNU - Overview: Manganese, 24 Hour, Urine

Monitoring manganese exposure using 24 hour urine collections Nutritional monitoring

MET - Overview: Methemoglobin and Sulfhemoglobin, Blood

Diagnosing methemoglobinemia and sulfhemoglobinemia Identifying cyanosis due to other causes, such as congenital heart disease

LDPU - Overview: Limited Drug Profile, 3 Drug Classes, Immunoassay, Random, Urine

Detecting drug use involving barbiturates, cocaine, and carboxy-tetrahydrocannabinol This test is not intended for use in employment-related testing.

PBCU - Overview: Lead/Creatinine Ratio, Urine

Detecting clinically significant lead exposure using random urine specimens This test is not a substitute for blood lead screening.

KI67P - Overview: Ki-67(MIB-1), Pulmonary, Quantitative Immunohistochemistry, Automated

Determining proliferation of tumor cells in paraffin-embedded tissue blocks from patients diagnosed with carcinoid or atypical carcinoid of the lung including metastases

PBUOE - Overview: Lead Occupational Exposure, Random, Urine

Detecting clinically significant lead exposure due to occupational exposure This test is not a substitute for blood lead screening.

MNCU - Overview: Manganese/Creatinine Ratio, Urine

Measurement of manganese as a part of a profile Monitoring manganese exposure Nutritional monitoring Clinical trials

MNRCU - Overview: Manganese/Creatinine Ratio, Random, Urine

Monitoring manganese exposure using random urine specimens Nutritional monitoring Clinical trials

TIBC - Overview: Total Iron Binding Capacity, Serum

Screening for chronic iron overload diseases, particularly hereditary hemochromatosis

FRT4 - Overview: T4 (Thyroxine), Free, Serum

Evaluating suspected thyroid function disorders using free thyroxine measured together with thyroid-stimulating hormone

SIIRO - Overview: Sirolimus, Whole Blood

Monitoring whole blood sirolimus concentration during therapy, particularly in individuals coadministered cytochrome P450 (CYP) 3A4 substrates, inhibitors, or inducers Adjusting dose to optimize immunosuppression while minimizing...

VLTUX - Overview: Volatile Screen, Chain of Custody, Random, Urine

Detecting the presence of acetone, methanol, isopropanol, or ethanol in urine with subsequent quantitation Providing chain of custody for when the results of testing could be used in a court of law. Its purpose is to protect the rights of...

ZNUCR - Overview: Zinc/Creatinine Ratio, Random, Urine

Identifying the cause of abnormal serum zinc concentrations using a random urine specimen

ZONI - Overview: Zonisamide, Serum

Monitoring zonisamide therapy; recommended for all patients to ensure appropriate dosing Assessing medication compliance

VITAP - Overview: Vitamin A, Serum

Diagnosing vitamin A deficiency and toxicity as a part of a profile Monitoring vitamin A therapy

VLTS - Overview: Volatile Screen, Serum

Detection and quantitation of acetone, methanol, isopropanol, and ethanol in serum Quantification of the concentration of ethanol in serum correlates with degree of intoxication Evaluation of toxicity to the measured volatile substances

VLTB - Overview: Volatile Screen, Blood

Detection and quantitation of acetone, methanol, isopropanol, and ethanol in whole blood Quantification of the concentration of ethanol in blood that correlates with the degree of intoxication Evaluation of toxicity to the measured...

Site Search

Visit Mayo Clinic Laboratories at Medlab Middle East 2023 - Insights

announce our participation in Medlab Middle East 2023, a medical conference and exhibition taking place in Dubai, United Arab Emirates, Feb. 6–9, 2023....

the American Academy of Neurology Annual Meeting 2023 - Insights

Clinic Laboratories is thrilled to participate in the American Academy of Neurology Annual Meeting 2023....

Register today for Classical Hematology 2023 - Insights

Taking place on October 3–4, 2023, in Rochester, Minnesota, the Classical Hematology 2023 conference focuses on addressing the evaluation of frequently encountered blood count abnormalities. The conference...

the American Academy of Neurology Annual Meeting 2023 - Insights

the American Academy of Neurology Annual Meeting, taking place in person in Boston on April 22–27, 2023....

Leveraging the Laboratory 2023 - Insights

Mayo Clinic Laboratories’ Outreach Conference was held Sept. 26-27, 2023, in Chicago. “Leveraging the Laboratory: Dimensions of Outreach” provides innovative views into all aspects of health system laboratory...